Mallinckrodt - PharmaKB

Mallinckrodt(MNK)

Mallinckrodt Pharmaceuticals is an American-Irish domiciled manufacturer of specialty pharmaceuticals (namely, adrenocorticotropic hormone), generic drugs and imaging agents. In 2017 it generated 90% of its sales from the U.S. healthcare system. While Mallinckrodt is headquartered in Ireland for tax purposes, its operational headquarters are in the U.S. Mallinckrodt's 2013 tax inversion to Ireland drew controversy when it was shown Acthar was Medicaid's most expensive drug.

Trade Name	Drug Name	Approved	Patent Expires	Indication
Acthar	Corticotropin	1982-01-01	2041	Collagen diseases , Erythema multiforme , Infantile spasms , Multiple sclerosis , Nephrotic syndrome , Optic neuritis , Rheumatic diseases , Sarcoidosis , Serum sickness , Uveitis
Anexsia	Acetaminophen, Hydrocodone	2002-10-31	2025-2039	Fever , Pain
Angio-conray	Iothalamate	1982-01-01		—
Baros	Bicarbonate, Tartaric acid	1985-08-07		—
Bucet	Acetaminophen, Butalbital	1985-06-28	2025-2039	Fever, Pain
Butalbital, acetaminophen caffeine	Acetaminophen, Butalbital, Caffeine	1985-03-27	2025-2039	Fever, Pain
Cholebrine	Iocetamic acid	1982-01-01		—
Conray	Iothalamate	1982-01-01		—
Femcet	Acetaminophen, Butalbital, Caffeine	1985-06-19	2025-2039	Fever, Pain
Hydrocodone acetaminophen	Acetaminophen, Hydrocodone	1995-06-01	2025-2039	Fever, Pain